Botanical species · safety record

Clematis vitalba

The EFSA Compendium of Botanicals holds 4 constituent measurements for Clematis vitalba. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Clematis vitalba L.

4Constituent measurements

0Safety records

3Cited sources

35Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 35 licensed products naming Clematis vitalba as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Flower
Flowers
Flowers on stalk
Fresh leaves

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Hederagenin	Roots and other underground parts	Solvent extraction	—	Chromatographic tests	Resolve DOI
Pentacyclic triterpene saponins	Roots and other underground parts	Solvent extraction	—	Chromatographic tests	Resolve DOI
Magnoflorine	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Protoanemonin	Leaves	Essential oil	150 Microgram/gram	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Chirva, V.Ya., Kintya, P.K., Mel'nikov, V.N. Ribose in the triterpene glycosides of Clematis vitalba. I. Chemistry of natural compounds, 1971, vol. 7, no. 3, p. 284-286. DOI
Slavik, Jiri., Bochorakova, Jitka., Slavikova, Leonora. Occurrence of magnoflorine and corytuberine in some wild or cultivated plants of Czechoslovakia. Collection of Czechoslovak Chemical Communications, 1987, p. 804-811.
Bonora, A., Dall'Olio, G., Bruni, A. Separation and quantitation of protoanemonin in Ranunculaceae by normal- and reversed-phase HPLC. Planta Medica, 1985, p. 364-367.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature